The emergence of Ephexin5 as a therapeutic target in Alzheimer's disease

Expert Opin Ther Targets. 2019 Apr;23(4):263-265. doi: 10.1080/14728222.2019.1586884. Epub 2019 Mar 5.

Authors

Emily K Cook¹, Gabrielle L Sell², Thomas B Schaffer³, Seth S Margolis^{1

4}

Affiliations

¹ a Department of Biological Chemistry , The Johns Hopkins University School of Medicine , Baltimore , MD , USA.
² b Center for Neuroscience , University of California , Davis , CA , USA.
³ c Research and Development , Columbia Biosciences Corporation , Frederick , MD , USA.
⁴ d Solomon H. Snyder Department of Neuroscience , The Johns Hopkins University School of Medicine , Baltimore , MD , USA.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Alzheimer Disease / drug therapy*
Alzheimer Disease / physiopathology
Animals
Guanine Nucleotide Exchange Factors / metabolism*
Humans
Molecular Targeted Therapy*

Substances

ARHGEF15 protein, human
Guanine Nucleotide Exchange Factors

Grants and funding